
    
      -  Purpose of study- To assess the performance of PillCam SB3 capsule in detecting small
           bowel lesions in patients

        -  Study design- Feasibility study

        -  Number of subjects- Up to 200

        -  Subject population- Patients with symptoms suggestive of small bowel disease and whom
           are eligible and indicated for SB capsule endoscopy

        -  No of centers- 4

        -  Duration of enrollment up to 12 months from IRB approval to enroll study patients

        -  Duration of follow-up 1 week after capsule procedure.

        -  Primary objectives To evaluate the performance of SB-3 system in patients as per
           physician questionnaire
    
  